CD2AP and neoplasm: Specifically, an elevation in the expression levels of PRN1, OXSM, SLC3A2, and CD2AP were observed in tumor tissues, while the expression levels of DSTN, FLNA, TLN1, IQGAP1, MYL6, NCKAP1, and NDUFS1 declined in tumor tissues (Fig. 2A).